Highest development stage: Phase 2

Development active

Gram-positive activity

Gram-negative activity

Combination therapy

Mechanism of Action/Target pathogen: Bacterial infections including gram-negative. Complicated urinary tract infections, complicated intra-abdominal infections, acute pyelonephritis (kidney infection), hospital-acquired bacterial pneumonia/ ventilator-associated bacterial pneumonia